Volga | Technology & innovation | Retail, FMCG

To make sure pharma products are authentic, see their digital passport

23 Sep '21
Two Russian companies, ANO Airalab Rus from Samara Oblast in the mid-Volga region and Innocolloid, Inc. from St. Petersburg, have been jointly working on what they refer to as “digital passport” for their new anti-viral blocker called Blokator.

The Blokator reportedly demonstrates disinfectant properties and is designed to thwart viral and microbial activity. Tests are said to have proved its efficacy in inhibiting human respiratory viruses—but the solution is not a drug in a strict therapeutic sense of the word.

The Russian solution is meant to compete with Japanese anti-viral blockers that currently dominate the blockers market.
Publish in Twitter
Write to Facebook
Google Buzz
Write to LiveJournal
Show in MM
Share MK
Find Related Content

Locations: Samarskaya oblast

Tags: human respiratory viruses (0) / digital passport (0) / Innocolloid (0) / Blokator (0) / ANO Airalab Rus (0) /

Latest News: Volga
7 Oct '21 | Technology & innovation
28 Sep '21 | Technology & innovation
23 Sep '21 | Technology & innovation | Retail, FMCG
20 Aug '21 | Technology & innovation

Feature stories

8 Oct '21
Chemists at the St. Petersburg State University...
2 Aug '21
From enhancing the properties of existing materials...
24 May '21
Biophysicists have looked into the way vitally...
Search (News archive - 22776)
Marchmont Tech Solutions_ENG
Marchmont News

Latest News

14 Oct '21
A Russian research team has developed a neural...
12 Oct '21
Academy of Change, a Russian online school, has...
8 Oct '21
Russian researchers have improved targeted treatment...

Most read stories from last week

15 Oct '21
15 Oct '21
The Rostov Regional Agency for Entrepreneurship...